<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Kuznar, Wayne</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Gascoyne, Randy</style></author><author><style face="normal" font="default" size="100%">Shipp, Margaret</style></author><author><style face="normal" font="default" size="100%">Küppers, Ralf</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Insights Into Pathophysiology of Lymphomas Help Identify Therapeutic Targets</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-12-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">26-27</style></pages><abstract><style  face="normal" font="default" size="100%">Understanding the pathophysiologic basis of lymphomas and the contribution of molecular and cellular features to their natural history is enabling identification of therapeutic targets. Drugs that hit some of these targets have already produced impressive responses in various lymphoma subsets.</style></abstract><number><style face="normal" font="default" size="100%">55</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>